Arrowhead to Report Fiscal 2014 Second Quarter Financial Results

– Conference Call Scheduled for Tuesday, May 6, 2014

PASADENA, Calif.–(BUSINESS WIRE)–

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical

company developing targeted RNAi therapeutics, today announced that it

will report its financial results for the fiscal 2014 second quarter

ended March 31, 2014, on Tuesday, May 6, 2014, at 4:30 p.m. EDT. To

participate in the conference call, please dial 855-215-6159 (toll free

from the US) or 315-625-6887 (for international callers) and enter

Conference ID 35127223. Investors may also access a live audio webcast

of this conference call on the Company’s website at http://www.arrowheadresearch.com/presentations.

A replay of the webcast will be available approximately two hours after

the conclusion of the call and will remain available for 90 days. An

audio replay will also be available approximately two hours after the

conclusion of the call and will be available for 7 days. The audio

replay can be accessed by dialing 855-859-2056 (toll free from the US),

or 404-537-3406 (for international callers) and entering Conference ID

35127223.

About Arrowhead Research Corporation

Arrowhead Research Corporation is a biopharmaceutical company developing

targeted RNAi therapeutics. The company is leveraging its proprietary

drug delivery technologies to develop targeted drugs based on the RNA

interference mechanism that efficiently silences disease-causing genes.

Arrowhead technologies also enable partners to create peptide-drug

conjugates that specifically home to cell types of interest while

sparing off-target tissues. Arrowhead’s pipeline includes clinical

programs in chronic hepatitis B virus and partner-based programs in

obesity and oncology.

For more information please visit http://www.arrowheadresearch.com,

or follow us on Twitter @ArrowRes.

To be added to the Company’s email list to receive news directly, please

send an email to ir@arrowres.com.

Arrowhead Research Corporation
Vince Anzalone, CFA
626-304-3400
ir@arrowres.com
or
Investor

Relations:
The Trout Group
Lauren Glaser
646-378-2972
ir@arrowres.com
or
Media:
Russo

Partners
Martina Schwarzkopf, Ph.D.
212-845-4292
martina.schwarzkopf@russopartnersllc.com

Source: Arrowhead Research Corporation

News Provided by Acquire Media